Techs a fast-growing segment at NLPB Hydroxychloroquine for COVID-19 prevention or treatment lacks clinical evidencePharmacy and medical organizations issue statements to discourage off-label prescribing Coronavirus: Canada's response hits a turning point Due to the speed at which COVID-19 spreads, we need to move beyond learning about the risk and start putting an operational plan in place One in five Canadians think COVID-19 pandemic blown out of proportion: poll The poll suggests that 18- to 34-year-olds were most likely to think the crisis is overblown Dire scenario for intensive care even if COVID-19 infection rate drops: study That scenario assumes the average daily rate of infections over 37 days would be 7.5% compared with the 26% daily rate that Canada has experienced recently Aerosol and fomite transmission SARS-CoV-2 is plausible NEJM: presence in aerosol of SARS-CoV-2 similar to that of CoV-1 COVID-19 drug therapy options: An update No therapies have been proven effective for preventing or treating COVID-19; however, there are some promising options NEJM study finds coronavirus viable in lab-made aerosols for up to three hours According to experts, the stability of the virus in a real-world environment may differ considerably than what was found in the lab Anterior hip replacement approach found to increase complications 5 ways to put evidence into action during outbreaks like COVID-19 Medical workers in health crisis zones need access to research evidence to inform decisions First Previous 273 274 275 276 277 Next Last
